Invention Grant
- Patent Title: Perfusion bioreactor with filtration systems
-
Application No.: US17524269Application Date: 2021-11-11
-
Publication No.: US11434464B2Publication Date: 2022-09-06
- Inventor: Jiuyi Lu , Jason Walther , Jonathan Wang , Kevin Victor Chen
- Applicant: Genzyme Corporation
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Agency: Mcdonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: B01D15/18
- IPC: B01D15/18 ; B01D61/18 ; B01D61/22 ; C12M1/36 ; C12M1/00 ; C12M1/34

Abstract:
The disclosure provides a filtration system for a cell culture apparatus and a method of cell culture. The filtration system comprises a bioreactor vessel and two or more alternating tangential flow (ATF) filters connected in parallel. A failure in either filter is detected by an in-line sensor, and an automated response system functions to sequester the malfunctioning filter by stopping the flow of liquid media through the filter. Media flow through the remaining operable filters can be increased so that the rate of perfusion through the bioreactor remains relatively unchanged. Such a system may prevent issues that arise from ATF filter failures in conventional perfusion bioreactors, thereby improving the long-term viability of cell cultures.
Public/Granted literature
- US20220073861A1 Perfusion Bioreactor With Filtration Systems Public/Granted day:2022-03-10
Information query